Snapshot from Jun 25, 2026 at 22:38 UTC. For live data and tracking: View Live
Entities / Olaparib
Other

Olaparib

Tracked across 1 events · 6 articles · First seen Jun 11, 2026 · Last active Jun 11, 2026

Sentiment
20
Attention
4
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (1)
4 20
Regulatory
Roche VENTANA MMR RxDx Panel IVDR Approval
Roche announced the European Union In Vitro Diagnostic Regulation (IVDR) approval of several label expansions for its VENTANA MMR RxDx Panel. This immunohistochemistry (IHC) companion diagnostic test identifies cancer patients' mismatch repair (MMR) status, which…
Impact: Olaparib is a therapy for which the VENTANA MMR RxDx Panel acts as a companion diagnostic, helping to identify eligible patients.
Jun 11, 2026 · 6 articles
NEWSDESK
Track Olaparib live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.